New early clinical trial results have indicated that an injection of a candidate monoclonal antibody (mAb) known as L9LS is both safe and highly protective against the malaria parasite.

The unconventional materials, sponge and sugar, have been used to develop novel medical electrodes to provide a low–cost alternative to standard silver-based electrodes, with improved skin attachment and adhesion time.

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

A qualitative study has been set up to explore patient experiences in using a teledermatology service, during which digital images are sent to an expert to be reviewed at a later date.

Research presented at the American Society for Preventive Cardiology Congress on Cardiovascular Disease Prevention, has shown that the chronic inflammation attributed to moderate-to-severe psoriasis could accelerate the risks of cardiovascular disease.

What lies in wait for pharma in the social media jungle?

T2D remission (an HbA1c <48 mmol/mol without the use of glucose lowering medications for 6 months), improvements in cardiovascular risk factors, and decreased T2D-associated mortality can be achieved through sustained weight loss.

CoMiSSTM is a clinical tool developed to increase awareness among healthcare professionals (HCP) of possible symptoms of cow’s milk allergy (CMA) in infants. During this symposium, leading experts in the field of paediatric gastroenterology, allergy, and nutrition highlighted how CoMiSS can facilitate awareness of CMA and support HCPs in improving the patient journey from symptom presentation to diagnosis.